ARTICLE | Management Tracks
Rao to head Sobi R&D; plus new CMOs for Ikena, Agile, Nordic Nanovector and more
August 19, 2020 12:42 AM UTC
Swedish Orphan Biovitrum AB (SSE:SOBI) said Ravi Rao will succeed Milan Zdravkovic as head of R&D, effective Sept. 1. Rao joins the rare diseases company from Aeglea BioTherapeutics Inc. (NASDAQ:AGLE), where he was CMO. Prior to that he was VP, global medical head, immunology and specialty medicine franchise at GlaxoSmithKline plc (LSE:GSK; NYSE:GSK). Zdravkovic is pursuing new opportunities.
Ikena Oncology Inc. hired Sergio Santillana as CMO, succeeding Jason Sager. Formerly, Santillana held the same title at Merrimack Pharmaceuticals Inc. (NASDAQ:MACK). Sager will become a consultant to the company...